PETS

PetMed Express Inc

PETS, USA

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

https://www.1800petmeds.com

Stock Price

$ 0.00

0% increase compared to yesterday.

Dividend

Frequency:

N/A

Rate:

N/A

Next Payout:

N/A
PETS
stock
PETS

PetMed Express (PETS) Stock: $4 Takeover Proposal Sparks Surge — News, Forecasts, and Key Risks on Dec. 12, 2025 ts2.tech

Read more →
PETS
stock
PETS

Why Did Penny Stock Petmed Express (PETS) Soar over 68%? TipRanks

Read more →

Showing 2 of 10

Analyst Ratings & Sentiment

(Last Updated 2025-09-30)

Rating:

SELL

Target Price:

$2.75

Analyst Picks

Strong Buy

0

Buy

0

Hold

1

Sell

0

Strong Sell

1

Sentiment:

Bullish

Finn Analysis

(Last Updated 2025-09-30)

Health Score

Price to Book Ratio (P/B)

-

Very Low

0.78

Low ≤ 1

High ≥ 3

Return on Equity (ROE)

-

Very Low

-13.68 %

Low ≤ 5%

High ≥ 25%

Return on Assets (ROA)

-

Very Low

-7.83 %

Low ≤ 2%

High ≥ 10%

Free Cash Flow - Revenue % (FCF)

-

Medium

9.95 %

Low ≤ 5%

High ≥ 15%

Debt to Equity

-

Low

0.75

Low ≥ 1

High ≤ 0.3

Investors

* Institutions hold a combined 47.03% of the total shares of PetMed Express Inc

1.

Renaissance Technologies Corp

(6.1669%)

since

2025/06/30

2.

Vanguard Group Inc

(4.6671%)

since

2025/06/30

3.

Hotchkis & Wiley Capital Management LLC

(4.0031%)

since

2025/06/30

4.

Vanguard Total Stock Mkt Idx Inv

(2.9182%)

since

2025/07/31

5.

BlackRock Inc

(2.6374%)

since

2025/06/30

6.

Federated Hermes Inc

(2.3307%)

since

2025/06/30

7.

Dimensional Fund Advisors, Inc.

(2.2119%)

since

2025/06/30

8.

OAKTOP CAPITAL MANAGEMENT II LP

(2.11%)

since

2025/06/30

9.

Federated Hermes MDT Small Cap Core IS

(2.0104%)

since

2025/06/30

10.

Federated Hermes MDT SCC Institutional

(2.0104%)

since

2025/06/30

11.

Arrowstreet Capital Limited Partnership

(1.193%)

since

2025/06/30

12.

Hotchkis & Wiley Sm Cp Divers Val I

(1.1197%)

since

2025/07/31

13.

Geode Capital Management, LLC

(1.0607%)

since

2025/06/30

14.

Vanguard Institutional Extnd Mkt Idx Tr

(1.0256%)

since

2025/07/31

15.

Ameriprise Financial Inc

(0.6921%)

since

2025/06/30

16.

Multi-Manager Small Cap Eq Strat Inst

(0.6913%)

since

2025/07/31

17.

Man Group PLC

(0.6828%)

since

2025/06/30

18.

Citadel Advisors Llc

(0.6288%)

since

2025/06/30

19.

DFA US Targeted Value I

(0.5849%)

since

2025/07/31

20.

T. Rowe Price Associates, Inc.

(0.5812%)

since

2025/06/30

21.

Truffle Hound Capital, LLC

(0.5811%)

since

2025/06/30

22.

Principal SmallCap Value II Instl

(0.5803%)

since

2025/07/31

23.

Formidable Asset Management LLC

(0.5553%)

since

2025/06/30

24.

Fidelity Extended Market Index

(0.5457%)

since

2025/07/31

25.

State Street Corp

(0.4806%)

since

2025/06/30

26.

Invenomic Capital Management, LP

(0.4741%)

since

2025/06/30

27.

Invenomic Institutional

(0.4535%)

since

2025/04/30

28.

Royal Bank of Canada

(0.415%)

since

2025/06/30

29.

UBS Group AG

(0.3747%)

since

2025/06/30

30.

Bank of America Corp

(0.3737%)

since

2025/06/30

31.

iShares Core S&P Total US Stock Mkt ETF

(0.3734%)

since

2025/08/31

32.

Dimensional US Targeted Value ETF

(0.359%)

since

2025/08/29

33.

Invesco RAFI US 1500 Small-Mid ETF

(0.346%)

since

2025/08/29

34.

DFA US Small Cap Value I

(0.303%)

since

2025/07/31

35.

Empower Small Cap Value Inv

(0.2871%)

since

2025/06/30

36.

EA Bridgeway Omni Small-Cap Value ETF

(0.278%)

since

2025/08/29

37.

Dimensional US Small Cap Value ETF

(0.2398%)

since

2025/08/29

38.

T. Rowe Price Total Equity Market Idx

(0.2368%)

since

2025/07/31

39.

Hotchkis & Wiley Small Cap Div Val CL F

(0.2266%)

since

2025/08/31

40.

Extended Equity Market Fund K

(0.225%)

since

2025/06/30

* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.

Earnings History

EPS ActualEPS EstimateEPS DifferenceSurprise Percent

Upcoming Earnings Release

Date

2025-12-31

EPS Estimate

-0.06

Latest Release

Date

2025-09-30

EPS Actual

-0.56

EPS Estimate

-0.04

EPS Difference

-0.52

Surprise Percent

-1300%

Investing Fit Scorecard

(Last Updated 2025-09-30)

Deep Value
Strong Deep Value(7.5)
Defensive
Highly Defensive(6.5)
Dividend
Weak Dividend Profile(3)
Economic Moat
Wide Moat Company(6.8)
GARP
Fair GARP(3.5)
Growth
Weak Growth Prospect(2.5)
Momentum
Strong Momentum(6.5)
Net Net
Possible Net-Net(5.5)
Quality
Moderate Quality(4)
Value
Fair Value(5)

Income Statement

(Last Updated 2025-09-30)

Revenue

$ 0

Cost Of Revenue

$ 0

Gross Profit

$ 0

Operating Expenses

$ 0

Operating Income

$ 0

Interest Expense

$ 0

Pretax Income

$ 0

Net Income

$ 0

Income Tax Expense

$ 0

EBITDA

$ 0

Total Other Income Expense Net

$ 0

Earnings Per Share

0

Dividends Per Share

0

Shares Outstanding

0

Operating Margin

0%

Trend

Balance Sheet

(Last Updated 2025-09-30)

Cash

$ 0

Short Term Investments

$ 0

Receivables

$ 0

Inventories

$ 0

Total Current Assets

$ 0

Property Plant Equipment

$ 0

Total Assets

$ 0

Payables

$ 0

Short Term Debt

$ 0

Long Term Debt

$ 0

Total Liabilities

$ 0

Equity

$ 0

Trend

Cash Flow

(Last Updated 2025-09-30)

Net Income

$ 0

Depreciation

$ 0

Change In Working Capital

$ 0

Cash From Operations

$ 0

Capital Expenditures

$ 0

Cash From Investing

$ 0

Cash From Financing

$ 0

Net Change In Cash

$ 0

Trend

Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.